PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer
Clinical trial NCT02326168 · COMPLETED
Trial details
- NCT number
- NCT02326168
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.